Bentham Science Logo

Track Your Manuscript:


Current Cancer Drug Targets

Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access

Contents

Current Cancer Drug Targets, Volume 11 - Number 1










High Therapeutic Potential for Systemic Delivery of a Liposomeconjugated Herpes Simplex Virus

, 11(1): 111 - 122

T. Shikano, H. Kasuya, T. T. Sahin, N. Nomura, A. Kanzaki, M. Misawa, Y. Nishikawa, T. Shirota, S. Yamada, T. Fujii, H. Sugimoto, N. Kanazumi, S. Nomoto, S. Takeda and A. Nakao


DOI: 10.2174/156800911793743673


Human Equilibrative Nucleoside Transporter 1 (hENT1) Levels Predict Response to Gemcitabine in Patients With Biliary Tract Cancer (BTC)

, 11(1): 123 - 129

D. Santini, G. Schiavon, B. Vincenzi, C. E. Cass, E. Vasile, A. D. Manazza, V. Catalano, G. G. Baldi, R. Lai, S. Rizzo, A. Giacobino, L. Chiusa, M. Caraglia, A. Russo, J. Mackey, A. Falcone and G. Tonini


DOI: 10.2174/156800911793743600



Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.

Advertisement

webinar-July-21July-2021-ban

Related Journals

Related eBooks

eBooks Catalog